Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002044285-25-000012·Dauntless Investment Group, LLC
Schedule 13G ownership disclosure
KAZIA THERAPEUTICS LTD
American Depository Shares · CUSIP: 48669G105
Event date: 2025-09-30
- Filing-level shares
- 176,822.00
- Percent of class
- 9.9%
- Dauntless Investment Group, LLC
Shares: 176,822.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002044285-25-000012
- Form type
- SCHEDULE 13G/A
- Filer
- Dauntless Investment Group, LLC
- CIK
- CIK 2044285
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership